miR-21 acts as an oncogene in CCA, and their oncogenic property gets abrogated by incorporating ampelopsin in a dose-dependent manner through the miR-21/phosphatase and tensin homolog deleted on chromosome 10 (PTEN)/protein kinase B (Akt) pathway [107]. The gene discussed is PTEN; the disease is cholangiocarcinoma.